Jingfei Cheng

Title: Jingfei Cheng: Innovator in Methylation Analysis

Introduction

Jingfei Cheng is a notable inventor based in Oxford, GB. He has made significant contributions to the field of DNA analysis, particularly in the area of methylation. His innovative methods aim to enhance the efficiency and cost-effectiveness of genomic research.

Latest Patents

Jingfei Cheng holds a patent for a groundbreaking method titled "Bisulfite-free, whole genome methylation analysis." This patent provides methods for cost-effective bisulfite-free identification in DNA, including whole genomic DNA, of the locations of one or more of 5-methylcytosine, 5-hydroxymethylcytosine, 5-carboxylcytosine, and 5-formylcytosine. The methods described are based on the conversion of modified cytosine (5mC, 5hmC, 5fC, 5caC) to dihydrouracil (DHU), for example, by TET-assisted pyridine borane treatment, followed by endonuclease cleavage of the DHU, and identification of the cleavage site, which corresponds to the location of the modified cytosine. This patent showcases his innovative approach to genomic analysis.

Career Highlights

Jingfei Cheng is associated with the Ludwig Institute for Cancer Research Limited, where he applies his expertise in methylation analysis. His work is pivotal in advancing cancer research and understanding the genetic factors involved in various diseases.

Collaborations

Jingfei collaborates with talented individuals in his field, including Chunxiao Song and Paulina Siejka-Zielinska. Their combined efforts contribute to the advancement of research in methylation and genomic analysis.

Conclusion

Jingfei Cheng's contributions to the field of methylation analysis through his innovative patent and collaborative efforts highlight his role as a significant inventor in genomic research. His work continues to pave the way for advancements in understanding DNA modifications and their implications in health and disease.